Trial intelligence / Profile preview

Metoclopramide for gag reflex-related nausea during dental impression molding

IRCT20190223042808N1Phase 2Completed

Sponsor
Islamic Azad University
Start
Mar 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, open-label, single-arm trial of metoclopramide in nausea ((none)), sponsored by Islamic Azad University. Primary endpoints: Prevention of nausea reflex during molding and Change in nausea reflex intensity score. Started Mar 2019; status: completed.

02

Drugs

metoclopramide
03

Conditions

nausea ((none))

Beyond the preview

Go deeper on IRCT20190223042808N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20190223042808N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call